Search
Perspective Therapeutics Inc
CATXAdd to Watchlist
2.950USD
-0.025-0.84%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
336.44MMarket Cap
LossP/E TTM
Perspective Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Perspective Therapeutics Inc is 6.52, ranking 328 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.11, which is -34.94% below the recent high of -1.37 and -518.32% above the recent low of -13.04.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
